Spectrum Management Group’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-98
Closed -$14K 273
2019
Q1
$14K Buy
+98
New +$14.2K ﹤0.01% 208
2016
Q2
Sell
-5,164
Closed -$1.38M 240
2016
Q1
$1.38M Buy
5,164
+290
+6% +$83K 0.53% 25
2015
Q4
$1.52M Buy
4,874
+80
+2% +$23.8K 0.57% 21
2015
Q3
$1.3M Buy
4,794
+75
+2% +$23K 0.67% 13
2015
Q2
$1.43M Buy
4,719
+160
+4% +$47.7K 0.53% 15
2015
Q1
$1.36M Buy
+4,559
New +$1.3M 0.51% 16
2014
Q4
Sell
-4,554
Closed -$1.1M 146
2014
Q3
$1.1M Buy
4,554
+124
+3% +$27.8K 0.68% 18
2014
Q2
$988K Buy
+4,430
New +$917K 0.61% 23

Other funds holding AGN

Spectrum Management Group's AGN Position: Q2 2019 in Review

Spectrum Management Group sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 98 shares — an estimated $14K sold.

Spectrum Management Group first reported a position in AGN in Q2 2014 and held it in 8 quarters. The position peaked at $1.52M in Q4 2015. 970 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • Spectrum Management Group reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • Spectrum Management Group sold 98 Allergan plc shares in Q2 2019, an estimated $14K.
  • Spectrum Management Group first reported a position in Allergan plc in Q2 2014 and held it in 8 quarters.
  • Spectrum Management Group's Allergan plc position peaked at $1.52M in Q4 2015.
  • 970 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Spectrum Management Group's 13F filing for Q2 2019, filed 2 Aug 2019.